GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanopharmaceutics Inc (OTCPK:TGRP) » Definitions » Dividend Yield %

Nanopharmaceutics (Nanopharmaceutics) Dividend Yield % : 0.00% (As of Apr. 28, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Nanopharmaceutics Dividend Yield %?

As of today (2024-04-28), the Trailing Annual Dividend Yield of Nanopharmaceutics is 0.00%.

The historical rank and industry rank for Nanopharmaceutics's Dividend Yield % or its related term are showing as below:

TGRP's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.58
* Ranked among companies with meaningful Dividend Yield % only.

Nanopharmaceutics's Dividend Payout Ratio for the three months ended in Sep. 2018 was 0.00.

As of today (2024-04-28), the Forward Dividend Yield % of Nanopharmaceutics is 0.00%.

Nanopharmaceutics's Dividends per Share for the three months ended in Sep. 2018 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Nanopharmaceutics Dividend Yield % Historical Data

The historical data trend for Nanopharmaceutics's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanopharmaceutics Dividend Yield % Chart

Nanopharmaceutics Annual Data
Trend Dec15 Dec16 Dec17
Dividend Yield %
- - -

Nanopharmaceutics Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Nanopharmaceutics's Dividend Yield %

For the Biotechnology subindustry, Nanopharmaceutics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanopharmaceutics's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanopharmaceutics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Nanopharmaceutics's Dividend Yield % falls into.



Nanopharmaceutics Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Nanopharmaceutics  (OTCPK:TGRP) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Nanopharmaceutics Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Nanopharmaceutics's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanopharmaceutics (Nanopharmaceutics) Business Description

Traded in Other Exchanges
N/A
Address
14120 NW 126 Terrace, Alachua, FL, USA, 32615
Nanopharmaceutics Inc is a clinical-stage specialty pharmaceutical company. It is engaged in developing oral, topical, and injectable products for cancer, central nervous system (CNS) disorders, and infectious diseases. The company's pipeline products include Triapine, Ammonium Tetrathiomolybdate, and Aza-TdC targeting cancer; NanoBUP, PRX-3140, NP-18-2, and NP-18-3 targeting CNS; and Ramoplanin and NanoDOX.